Kodiak Sciences Inc Common Stock KOD
$39.98
-7.90%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $48.14
- Implied Upside
- +20.4%
- Price Target Range
- $15.00 – $80.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-03 | JP MorganAnupam Rama |
Maintains | Overweight | $56 → $66 |
| 2026-05-11 | Chardan CapitalDaniil Gataulin |
Upgrades | Neutral → Buy | $14 → $61 |
| 2026-03-27 | UBSMichael Yee |
Maintains | Buy | $50 → $80 |
| 2026-03-27 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $38 → $58 |
| 2026-02-10 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Buy | $38 |
| 2026-01-22 | HC Wainwright & Co.Matthew Caufield |
Maintains | Buy | $26 → $38 |
| 2026-01-07 | UBSMichael Yee |
Initiates coverage on | Buy | $50 |
| 2025-11-17 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $14 |
| 2025-11-17 | HC Wainwright & Co.Matthew Caufield |
Maintains | Buy | $24 → $26 |
| 2025-11-11 | HC Wainwright & Co.Matthew Caufield |
Upgrades | Neutral → Buy | $5 → $24 |
| 2025-10-24 | JP MorganAnupam Rama |
Upgrades | Neutral → Overweight | $15 → $24 |
| 2025-10-23 | LifeSci CapitalPatrick Dolezal |
Initiates coverage on | Outperform | $40 |
| 2025-10-06 | Chardan CapitalDaniil Gataulin |
Maintains | Neutral | $14 |
| 2025-09-25 | BarclaysGena Wang |
Upgrades | Underweight → Equal-weight | $7 → $17 |
| 2025-09-22 | JefferiesMaury Raycroft |
Initiates coverage on | Buy | $15 |
| 2025-08-18 | HC Wainwright & Co.Matthew Caufield |
Maintains | Neutral | $3 → $5 |
| 2025-08-14 | BarclaysGena Wang |
Maintains | Underweight | $4 → $7 |
| 2025-08-14 | JP MorganAnupam Rama |
Upgrades | Underweight → Neutral | $15 |
| 2025-03-31 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Neutral | $3 |
| 2024-12-09 | JefferiesMichael Yee |
Upgrades | Hold → Buy | $20 |
| 2024-11-15 | BarclaysGena Wang |
Maintains | Underweight | $3 → $4 |
| 2024-11-15 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Neutral | $3 |
| 2024-09-24 | HC Wainwright & Co.Matthew Caufield |
Reiterates | Neutral | $3 |
| 2024-09-05 | HC Wainwright & Co.Matthew Caufield |
Initiates coverage on | Neutral | $3 |
| 2024-04-04 | UBSEliana Merle |
Maintains | Neutral | $3 → $5 |
| 2024-04-01 | BarclaysGena Wang |
Maintains | Underweight | $2 → $3 |
| 2023-12-21 | UBSEliana Merle |
Maintains | Neutral | $4 → $3 |
| 2023-12-11 | Goldman SachsAndrea Tan |
Reinstates | Sell | $2 |
| 2023-11-17 | Capital OneZegbeh Jallah |
Upgrades | Equal-weight → Overweight | — |
| 2023-07-27 | UBSEliana Merle |
Downgrades | Buy → Neutral | $15 → $4 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $39.98
- Market Cap
- $2.72 billion
- 52-Week Range
- $4.21 – $47.84
- Average Volume
- 607K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.